Annual Working Capital
$523.53 M
+$314.99 M+151.04%
November 30, 2024
Summary
- As of February 7, 2025, NRIX annual working capital is $523.53 million, with the most recent change of +$314.99 million (+151.04%) on November 30, 2024.
- During the last 3 years, NRIX annual working capital has risen by +$278.67 million (+113.81%).
- NRIX annual working capital is now at all-time high.
Performance
NRIX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$523.53 M
+$153.79 M+41.59%
November 30, 2024
Summary
- As of February 7, 2025, NRIX quarterly working capital is $523.53 million, with the most recent change of +$153.79 million (+41.59%) on November 30, 2024.
- Over the past year, NRIX quarterly working capital has increased by +$360.19 million (+220.51%).
- NRIX quarterly working capital is now at all-time high.
Performance
NRIX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NRIX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +151.0% | +220.5% |
| 3 y3 years | +113.8% | +134.3% |
| 5 y5 years | +2155.0% | +134.3% |
NRIX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +151.0% | at high | +220.5% |
| 5 y | 5-year | at high | +2155.0% | at high | +2155.0% |
| alltime | all time | at high | +6593.1% | at high | +2155.0% |
Nurix Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | $523.53 M(+151.0%) | $523.53 M(+41.6%) |
| Aug 2024 | - | $369.75 M(+0.1%) |
| May 2024 | - | $369.44 M(+126.2%) |
| Feb 2024 | - | $163.35 M(-21.7%) |
| Nov 2023 | $208.54 M(-15.8%) | $208.54 M(+1.0%) |
| Aug 2023 | - | $206.46 M(-5.2%) |
| May 2023 | - | $217.75 M(-2.6%) |
| Feb 2023 | - | $223.45 M(-9.8%) |
| Nov 2022 | $247.79 M | $247.79 M(-13.8%) |
| Aug 2022 | - | $287.37 M(+22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2022 | - | $234.12 M(+9.2%) |
| Feb 2022 | - | $214.44 M(-12.4%) |
| Nov 2021 | $244.86 M(-3.6%) | $244.86 M(-20.4%) |
| Aug 2021 | - | $307.76 M(-11.9%) |
| May 2021 | - | $349.44 M(+33.0%) |
| Feb 2021 | - | $262.80 M(+3.5%) |
| Nov 2020 | $253.90 M(+993.6%) | $253.90 M(-21.4%) |
| Aug 2020 | - | $323.08 M(+99.0%) |
| May 2020 | - | $162.37 M(+599.3%) |
| Nov 2019 | $23.22 M(+196.8%) | $23.22 M |
| Nov 2018 | $7.82 M | - |
FAQ
- What is Nurix Therapeutics annual working capital?
- What is the all time high annual working capital for Nurix Therapeutics?
- What is Nurix Therapeutics annual working capital year-on-year change?
- What is Nurix Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly working capital year-on-year change?
What is Nurix Therapeutics annual working capital?
The current annual working capital of NRIX is $523.53 M
What is the all time high annual working capital for Nurix Therapeutics?
Nurix Therapeutics all-time high annual working capital is $523.53 M
What is Nurix Therapeutics annual working capital year-on-year change?
Over the past year, NRIX annual working capital has changed by +$314.99 M (+151.04%)
What is Nurix Therapeutics quarterly working capital?
The current quarterly working capital of NRIX is $523.53 M
What is the all time high quarterly working capital for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly working capital is $523.53 M
What is Nurix Therapeutics quarterly working capital year-on-year change?
Over the past year, NRIX quarterly working capital has changed by +$360.19 M (+220.51%)